Literature DB >> 21560020

Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.

Samar Hamdy1, Azita Haddadi, Anooshirvan Shayeganpour, John Samuel, Afsaneh Lavasanifar.   

Abstract

PURPOSE: Mannosylation of vaccines is a promising strategy to selectively target vaccine antigens to the mannose receptor expressed on dendritic cells (DCs). The purpose of this study was to investigate the effect of mannan (MN) chemically conjugated to poly(D, L-lactide-co-glycolic acid) (PLGA) nanoparticles (NPs) on antigen-specific T-cell responses elicited by a model antigen (ovalbumin, OVA) loaded in PLGA-NPs.
METHODS: In vitro T-cell proliferation assay was done to assess the ability of DCs treated with OVA-NPs (±MN decoration) to induce antigen-specific T-cell activation. The efficacy of this vaccination strategy was further evaluated in vivo, where T-cell proliferation was performed to evaluate activation of T-cell responses in lymph nodes and spleens isolated from the vaccinated mice.
RESULTS: Our results demonstrate that MN-decorated antigen-loaded PLGA-NPs simultaneously enhanced antigen-specific CD4+ and CD8+ T-cell responses compared to non-decorated NPs.
CONCLUSIONS: MN decoration of PLGA-NPs is a promising strategy for enhancing antigen-specific T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21560020     DOI: 10.1007/s11095-011-0459-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

Review 1.  Vaccines that facilitate antigen entry into dendritic cells.

Authors:  Anita Gamvrellis; David Leong; Jennifer C Hanley; Sue D Xiang; Patricia Mottram; Magdalena Plebanski
Journal:  Immunol Cell Biol       Date:  2004-10       Impact factor: 5.126

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes.

Authors:  Socorro Espuelas; Christine Thumann; Béatrice Heurtault; Francis Schuber; Benoît Frisch
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

4.  Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells.

Authors:  Karen L White; Thomas Rades; Richard H Furneaux; Peter C Tyler; Sarah Hook
Journal:  J Pharm Pharmacol       Date:  2006-06       Impact factor: 3.765

Review 5.  Mannose receptor-targeted vaccines.

Authors:  Tibor Keler; Venky Ramakrishna; Michael W Fanger
Journal:  Expert Opin Biol Ther       Date:  2004-12       Impact factor: 4.388

6.  Poly(I:C) coated PLGA microparticles induce dendritic cell maturation.

Authors:  Christian Wischke; Julian Zimmermann; Benjamin Wessinger; Andreas Schendler; Hans-Hubert Borchert; J Hinrich Peters; Thomas Nesselhut; Dirk R Lorenzen
Journal:  Int J Pharm       Date:  2008-09-04       Impact factor: 5.875

7.  Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.

Authors:  Praveen Elamanchili; Manish Diwan; Min Cao; John Samuel
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

8.  Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers.

Authors:  Simon Heuking; Sarah Adam-Malpel; Emmanuelle Sublet; Antonio Iannitelli; Antonio di Stefano; Gerrit Borchard
Journal:  J Drug Target       Date:  2009-09       Impact factor: 5.121

9.  Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.

Authors:  Samar Hamdy; Ommoleila Molavi; Zengshuan Ma; Azita Haddadi; Aws Alshamsan; Zahra Gobti; Sara Elhasi; John Samuel; Afsaneh Lavasanifar
Journal:  Vaccine       Date:  2008-08-03       Impact factor: 3.641

10.  Structural analysis of the intact polysaccharide mannan from Saccharomyces cerevisiae yeast using 1H and 13C NMR spectroscopy at 750 MHz.

Authors:  E Vinogradov; B Petersen; K Bock
Journal:  Carbohydr Res       Date:  1998-02       Impact factor: 2.104

View more
  30 in total

1.  Dendritic cell targeted vaccines: Recent progresses and challenges.

Authors:  Pengfei Chen; Xinsheng Liu; Yuefeng Sun; Peng Zhou; Yonglu Wang; Yongguang Zhang
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 2.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 3.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

4.  Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination.

Authors:  Sejin Son; Jutaek Nam; Ilia Zenkov; Lukasz J Ochyl; Yao Xu; Lindsay Scheetz; Jinjun Shi; Omid C Farokhzad; James J Moon
Journal:  Nano Lett       Date:  2020-02-10       Impact factor: 11.189

5.  Presentation Modality of Glycoconjugates Modulates Dendritic Cell Phenotype.

Authors:  N A Hotaling; D M Ratner; R D Cummings; J E Babensee
Journal:  Biomater Sci       Date:  2014-10-01       Impact factor: 6.843

Review 6.  Engineering nano- and microparticles to tune immunity.

Authors:  James J Moon; Bonnie Huang; Darrell J Irvine
Journal:  Adv Mater       Date:  2012-05-29       Impact factor: 30.849

7.  Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles.

Authors:  Ying-Chun Lo; Michael A Edidin; Jonathan D Powell
Journal:  J Immunol       Date:  2013-10-04       Impact factor: 5.422

8.  Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.

Authors:  Michiko Hyakumura; Renae Walsh; Morten Thaysen-Andersen; Natalie J Kingston; Mylinh La; Louis Lu; George Lovrecz; Nicolle H Packer; Stephen Locarnini; Hans J Netter
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

9.  Glycan recognition by human blood mononuclear cells with an emphasis on dendritic cells.

Authors:  Eugenia M Rapoport; Sergey V Khaidukov; Andrey M Gaponov; Galina V Pazynina; Svetlana V Tsygankova; Ivan M Ryzhov; Ivan M Belyanchikov; Panagiota Milona; Nicolai V Bovin; Kenneth C McCullough
Journal:  Glycoconj J       Date:  2018-01-31       Impact factor: 2.916

Review 10.  Targeting human dendritic cells in situ to improve vaccines.

Authors:  Kartik Sehgal; Kavita M Dhodapkar; Madhav V Dhodapkar
Journal:  Immunol Lett       Date:  2014-07-27       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.